Menopause: Definition, Pathophysiology, Symptoms and Long-Term Effects

By Guillermo Salinas Araya · June 1, 2026 · Educational Material

The female body undergoes hormonal transitions that medicine is only now learning to interpret correctly. The 2012 STRAW+10 revision completely reclassified the diagnostic criteria for the menopausal transition — and most practitioners still haven't adopted these updated criteria.

Medical Definition of Menopause

The term menopause refers to a clinical condition with diagnostic criteria established in recent medical literature. Understanding it requires distinguishing between the entity itself, its presentations, and its underlying mechanisms. Updated international guidelines have reformulated several of these criteria over the past decade, expanding what conventional clinical practice has yet to incorporate.¹

Pathophysiology: How It Develops

The pathophysiological cascade of menopause involves multiple parallel mechanisms that feed into each other. The monocausal hypothesis has been replaced by integrative models that recognize the interaction of several axes:²

• Endocrine-metabolic axis: altered insulin sensitivity and hepatic lipogenesis.
• Inflammatory axis: low-grade pro-inflammatory cytokines (TNF-α, IL-6, elevated high-sensitivity CRP).
• Mitochondrial axis: respiratory chain dysfunction and increased reactive oxygen species.
• Intestinal axis: microbiome alterations, increased intestinal permeability, endotoxin translocation.
• Neuroendocrine axis: dysregulation of the hypothalamic-pituitary-adrenal axis with chronically elevated cortisol.

The simultaneous accumulation of these five impacts is what distinguishes the pathological state from the physiological state of compensatory tolerance. Patients may spend years with one or two active axes without clinical manifestations — until convergence overwhelms adaptive mechanisms.

Clinical Signs and Symptoms

Clinical presentation is heterogeneous. In early stages, most patients are oligosymptomatic or asymptomatic.³ Signs and symptoms that suggest the diagnosis include:

• Unexplained fatigue, especially postprandial
• Progressive increase in waist circumference
• Skin changes (spots, skin tags, hair alterations)
• Sleep-wake cycle disturbances
• Neurocognitive symptoms: brain fog, difficulty concentrating, irritability
• Nonspecific laboratory findings: mildly elevated CRP, minor liver function or lipid abnormalities frequently categorized as "high normal"
• Subtle ultrasound findings requiring targeted examination

Long-Term Consequences If Left Unaddressed

The natural history of menopause without adequate intervention involves silent but predictable progression:⁴

• Increased cardiovascular risk independent of cholesterol levels
• Accelerated progression to type 2 diabetes in patients with prediabetes
• Progression toward structural organ damage within 5 to 15 years
• Increased cancer risk documented in longitudinal cohorts
• Progressive functional decline that reduces quality of life and health span

The therapeutic window of opportunity — the period during which the condition is completely reversible — is proportional to exposure time and the number of compromised pathophysiological axes. Each year lost without comprehensive intervention narrows that window.

Can It Be Reversed?

Contemporary clinical evidence is conclusive: in pre-irreversible stages, reversal is possible. But it requires addressing all five pathophysiological axes simultaneously, not sequentially or in isolation. This is where conventional approaches fail: they intervene on a single axis while leaving the other four active.

The educational protocol we've designed — The Salinas Method — consists of 8 sequential phases. Each phase addresses a distinct mechanism in the cascade. Phases 1 and 2 prepare the cellular terrain and correct the microbiome. Phases 3 through 6 dismantle low-grade inflammation, mitochondrial dysfunction, insulin resistance, and cortisol axis disruption. Phases 7 and 8 consolidate the change and prevent recurrence.

This is not a diet. It's not isolated fasting. It's not a supplement. It's a step-by-step guided educational protocol, based on the most recent clinical evidence and designed so patients understand the rationale behind each action.

References

1. Davis SR, et al. Menopause. Nat Rev Dis Primers. 2015. PubMed
2. Santoro N, et al. The Menopause Transition: Signs, Symptoms, and Management Options. J Clin Endocrinol Metab. 2021. PubMed
3. Goodman NF, et al. AACE PCOS Clinical Practice Guidelines. Endocr Pract. 2015. PubMed
4. Rotterdam ESHRE/ASRM. Revised 2003 consensus on diagnostic criteria for PCOS. Hum Reprod. 2004. PubMed
5. Harlow SD, et al. STRAW+10 Collaborative Group. J Clin Endocrinol Metab. 2012. PubMed

100% educational material. Does not replace personal medical consultation. References verifiable on PubMed.